NCT00437255View on ClinicalTrials.gov

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Plaque Psoriasis
Interventions
DRUG

Clobetasol Propionate, 0.05%

Topical, twice daily for 4 weeks

DRUG

Calcipotriene and betamethasone dipropionate ointment

Topical, once daily

Trial Locations (4)

55432

Minnesota Clinical Study Center, Fridley

75230

Baylor Research Institute, Dallas

77802

J & S Studies, Inc., Bryan

78759

DermResearch, Inc., Austin

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY